Lupin en las noticias
Formulaciones e ingredientes farmacéuticos
Tamtam encontró 20 artículos recientes sobre Lupin.
- Lupin Receives US FDA Approval for Amifampridine Tablets, 10 mg
- Lupin stock: Postal ballot seeks approval for Akhil Gupta's board seat
- Stock Picks Today: NSE, ABB India, Lupin, Syrma And More On Brokerages' Radar
- Lupin: Nomura raises target price to Rs 2,780, sees nearly 40% upside as valuations turn attractive
- Lupin seeks shareholder approval for Akhil Gupta's independent director role
- Buzzing stocks: Meesho, Clean Max, Lupin, IOC, NBCC, NCL Ind, Zee, Edelweiss, Jujhar Logistics, Ola
- Lupin Launches Ranibizumab Biosimilar Across Europe in Partnership with Sandoz
- Lupin launches biosimilar Ranibizumab in Europe
- Lupin announces European launch of biosimilar Ranluspec
- Lupin Announces European Launch of Biosimilar Ranibizumab - Lupin | Press Release
- European Commission Approves Lupin’s Ranibizumab Biosimilar
- Lupin’s partner debuts ranibizumab biosimilar in Europe
- Pharma sector stocks today, November 11: Alembic Pharma gains 2.82%; Divi's Laboratories falls 2.08%, Lupin down 1.25%
- Lupin Targets Complex Drugs To Drive Next Phase Of Growth, Plans Higher U.S. Manufacturing
- Accumulate Lupin; target of Rs 2250: Prabhudas Lilladher
- Broker’s Call: Lupin (Accumulate)
- Lupin Q2 Review: Systematix Revises Target Price, Remains Cautious On US Recovery
- Lupin Q2 Review: Jefferies Cuts Target 15%, Flags US Competition; Kotak Retains Add
- Propranolol: Cardinol LA 160 mg is changing to Propranolol LA Lupin
- Lupin Q2 net profit falls 22.19% to ₹1,155.3 crore
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Lupin?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares